Journalist Hunt

JournalistsPricingBlogs
LoginSign up

Ingo K. Mellinghoff - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Ingo K. Mellinghoff's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Ingo K. Mellinghoff

Ingo K. Mellinghoff

Verified

Associate Editor, Journal of Global Oncology

Beats

Primary beats

Health

Secondary beats

Celebrity Charity EventsMusic NewsCheatingHome Gym EquipmentSustainable ProductsSpaMental HealthHealthcareBreaking NewsHuman-InterestDate NightsMedical ResearchCareerHard NewsHip-Hop

Final Covers

outdoors healthy eatingFitness healthy living

Doesn’t Cover

Other than the above. I do not write about other topics.

Journalist Type

-

Seniority Positions

Associate

Industries

Medium Formats

-

Content

Total articles 15

  • Ivosidenib in Isocitrate Dehydrogenase 1 - Mutated Advanced Glioma

    By Ingo K. Mellinghoff, Benjamin M. Ellingson, Mehdi Touat, Institut Gustave Roussy| hal.science@ Article Dans Une Revue Journal of Clinical Oncology Année : 2020 Ivosidenib in Isocitrate Dehydrogenase 1 – Mutated Advanced Glioma Fichier principal mellinghoff-et-al-2020-ivosidenib-in-isocitrate-dehydrogenase-1-mutated-advanced-glioma.pdf (1019.09 Ko) Télécharger le fichier Origine : Fichiers éditeurs autorisés sur une archive ouverte Licence : CC BY NC ND - Paternité - Pas d'utilisation commerciale - Pas de modification hal-04481741 , version 1 (28-02-2024) Ingo K Mellinghoff, Benjamin M...

    By Ingo K. Mellinghoff, Benjamin M. Ellingson, Mehdi Touat, Institut Gustave Roussy · hal.science

    Feb. 28, 2024

  • Flashback Foreword: Bevacizumab and Irinotecan in Recurrent Glioblastoma

    By Ingo K. Mellinghoff| brnw.ch@ Your PrivacyASCO is committed to transparency regarding our websites and the ways we process data. When you visit our site, we may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences, your location, or your device and is mostly used to make the site work as you expect it to and to personalize your web experience with us. Because we respect your right to privacy, you can choose not to allow some or all types of cookies.

    By Ingo K. Mellinghoff · brnw.ch

    Nov. 07, 2023

  • Ivosidenib in Isocitrate Dehydrogenase 1 - Mutated Advanced Glioma

    By Ingo K. Mellinghoff, Benjamin M. Ellingson, Mehdi Touat, Institut Gustave Roussy| hal.science@ Article Dans Une Revue Journal of Clinical Oncology Année : 2020 Ivosidenib in Isocitrate Dehydrogenase 1 – Mutated Advanced Glioma Fichier principal mellinghoff-et-al-2020-ivosidenib-in-isocitrate-dehydrogenase-1-mutated-advanced-glioma.pdf (1019.09 Ko) Télécharger le fichier Origine : Fichiers éditeurs autorisés sur une archive ouverte Licence : CC BY NC ND - Paternité - Pas d'utilisation commerciale - Pas de modification hal-04481741 , version 1 (28-02-2024) Ingo K Mellinghoff, Benjamin M...

    By Ingo K. Mellinghoff, Benjamin M. Ellingson, Mehdi Touat, Institut Gustave Roussy · hal.science

    Feb. 28, 2024

As seen in

Jama (The Journal Of The American Medical Association),Hemonc Today,Nature,Cell Press,Journal Of Global Oncology,Jama: Journal Of The American Medical Association

Company Info

Journal of Global Oncology

New York, New York, United States

+1 212-639-2000